135 related articles for article (PubMed ID: 10379660)
1. Gas chromatographic-mass spectrometric analysis of perillyl alcohol and metabolites in plasma.
Zhang Z; Chen H; Chan KK; Budd T; Ganapathi R
J Chromatogr B Biomed Sci Appl; 1999 May; 728(1):85-95. PubMed ID: 10379660
[TBL] [Abstract][Full Text] [Related]
2. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
3. R-Limonene metabolism in humans and metabolite kinetics after oral administration.
Schmidt L; Göen T
Arch Toxicol; 2017 Mar; 91(3):1175-1185. PubMed ID: 27325307
[TBL] [Abstract][Full Text] [Related]
4. Intranasal administration of perillyl alcohol-loaded nanoemulsion and pharmacokinetic study of its metabolite perillic acid in plasma and brain of rats using ultra-performance liquid chromatography/tandem mass spectrometry.
da Silva Santos J; Diedrich C; Machado CS; da Fonseca CO; Khalil NM; Mainardes RM
Biomed Chromatogr; 2021 Apr; 35(4):e5037. PubMed ID: 33238042
[TBL] [Abstract][Full Text] [Related]
5. Phase I clinical trial of perillyl alcohol administered daily.
Ripple GH; Gould MN; Stewart JA; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Pomplun M; Wilding G; Bailey HH
Clin Cancer Res; 1998 May; 4(5):1159-64. PubMed ID: 9607573
[TBL] [Abstract][Full Text] [Related]
6. A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days.
Bailey HH; Wilding G; Tutsch KD; Arzoomanian RZ; Alberti D; Feierabend C; Simon K; Marnocha R; Holstein SA; Stewart J; Lewis KA; Hohl RJ
Cancer Chemother Pharmacol; 2004 Oct; 54(4):368-76. PubMed ID: 15205914
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous measurement of perillyl alcohol and its metabolite perillic acid in plasma and lung after inhalational administration in Wistar rats.
de Lima DC; Rodrigues SV; Boaventura GT; Cho HY; Chen TC; Schönthal AH; Da Fonseca CO
Drug Test Anal; 2020 Feb; 12(2):268-279. PubMed ID: 31800149
[TBL] [Abstract][Full Text] [Related]
8. High-performance liquid chromatographic and pharmacokinetic analyses of an intravenous submicron emulsion of perillyl alcohol in rats.
Hua HY; Zhao YX; Liu L; Ye QX; Ge SW
J Pharm Biomed Anal; 2008 Dec; 48(4):1201-5. PubMed ID: 18849133
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.
Phillips LR; Malspeis L; Supko JG
Drug Metab Dispos; 1995 Jul; 23(7):676-80. PubMed ID: 7587953
[TBL] [Abstract][Full Text] [Related]
10. Gas chromatographic-mass spectrometric analysis of d-limonene in human plasma.
Wang S; Chen Y; Gao Z; Xiong M; Zhong Z; Ye L
J Pharm Biomed Anal; 2007 Sep; 44(5):1095-9. PubMed ID: 17540528
[TBL] [Abstract][Full Text] [Related]
11. Phase I clinical and pharmacokinetic study of perillyl alcohol administered four times a day.
Ripple GH; Gould MN; Arzoomanian RZ; Alberti D; Feierabend C; Simon K; Binger K; Tutsch KD; Pomplun M; Wahamaki A; Marnocha R; Wilding G; Bailey HH
Clin Cancer Res; 2000 Feb; 6(2):390-6. PubMed ID: 10690515
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of d-limonene in the rat by GC-MS assay.
Chen H; Chan KK; Budd T
J Pharm Biomed Anal; 1998 Aug; 17(4-5):631-40. PubMed ID: 9682146
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and biotransformation of the anticancer drug perillyl alcohol in PC12 cells and in the rat.
Boon PJ; van der Boon D; Mulder GJ
Toxicol Appl Pharmacol; 2000 Aug; 167(1):55-62. PubMed ID: 10936079
[TBL] [Abstract][Full Text] [Related]
14. Analysis of perillic acid in plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.
Ikechukwu Ezennia E; Phillips LR; Wolfe TL; Esmail Tabibi S
J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):354-8. PubMed ID: 9061476
[TBL] [Abstract][Full Text] [Related]
15. Sensitive biomonitoring of monoterpene exposure by gas chromatographic-mass spectrometric measurement of hydroxy terpenes in urine.
Sandner F; Fornara J; Dott W; Hollender J
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Nov; 780(2):225-30. PubMed ID: 12401347
[TBL] [Abstract][Full Text] [Related]
16. Identification of metabolites of the antitumor agent d-limonene capable of inhibiting protein isoprenylation and cell growth.
Crowell PL; Lin S; Vedejs E; Gould MN
Cancer Chemother Pharmacol; 1992; 31(3):205-12. PubMed ID: 1464157
[TBL] [Abstract][Full Text] [Related]
17. Human metabolism of the experimental cancer therapeutic agent d-limonene.
Crowell PL; Elson CE; Bailey HH; Elegbede A; Haag JD; Gould MN
Cancer Chemother Pharmacol; 1994; 35(1):31-7. PubMed ID: 7987974
[TBL] [Abstract][Full Text] [Related]
18. Sensitive capillary gas chromatographic-mass spectrometric-selected-ion monitoring method for the determination of diclofenac concentrations in human plasma.
Borenstein MR; Xue Y; Cooper S; Tzeng TB
J Chromatogr B Biomed Appl; 1996 Oct; 685(1):59-66. PubMed ID: 8930754
[TBL] [Abstract][Full Text] [Related]
19. A gas chromatographic-positive ion chemical ionization-mass spectrometric method for the determination of I-alpha-acetylmethadol (LAAM), norLAAM, and dinorLAAM in plasma, urine, and tissue.
Moody DE; Crouch DJ; Sakashita CO; Alburges ME; Minear K; Schulthies JE; Foltz RL
J Anal Toxicol; 1995 Oct; 19(6):343-51. PubMed ID: 8926727
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of protein prenylation by metabolites of limonene.
Hardcastle IR; Rowlands MG; Barber AM; Grimshaw RM; Mohan MK; Nutley BP; Jarman M
Biochem Pharmacol; 1999 Apr; 57(7):801-9. PubMed ID: 10075086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
